Savonix Revenue and Competitors
Estimated Revenue & Valuation
- Savonix's estimated annual revenue is currently $466.9k per year.
- Savonix's estimated revenue per employee is $33,350
- Savonix's total funding is $16.2M.
Employee Data
- Savonix has 14 Employees.
- Savonix grew their employee count by -42% last year.
Savonix's People
Name | Title | Email/Phone |
---|
Savonix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.9M | 29 | 4% | N/A | N/A |
#2 | $43.4M | 272 | 8% | N/A | N/A |
#3 | $14.1M | 97 | 11% | N/A | N/A |
#4 | $1460M | 8291 | 7% | $1.1B | N/A |
#5 | $310M | 1527 | 20% | N/A | N/A |
#6 | $194.1M | 956 | -5% | N/A | N/A |
#7 | $223.9M | 1080 | -33% | $101.6M | N/A |
#8 | $581.3M | 2708 | 9% | $253.1M | N/A |
#9 | $716.2M | 3528 | 2% | N/A | N/A |
#10 | $801.4M | 3948 | 52% | N/A | N/A |
What Is Savonix?
The Savonix vision is a world without dementia. We deliver a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet. Savonix Mobile is an accurate, accessible and affordable tool for professional cognitive screening. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuro-psychologists, neuroscientists and IT leaders, Savonix sets the global standard on cognition and its relationship to risk, health outcomes and the development of innovative therapies. Savonix evidence-based tests are digitally validated versions of the gold standard cognition tests, many of which neuropsychologists have used effectively since the 1930s.
keywords:Personal Health, Corporate Wellness, Health and Wellness, Brain Health$16.2M
Total Funding
14
Number of Employees
$466.9k
Revenue (est)
-42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Savonix News
Browse market information, tables and figures extent in-depth TOC on Cognitive Assessment and Training Market by Application (Savonix,...
– Savonix and Boston University School of Public Health launches the first-ever population health Alzheimer’s Disease Discovery Study (ASSIST) to digitally collect brain health data from over 400k participants. – First-ever wholly digital population health study that captures data from multiple ...
Savonix is a global leader in cognitive health that has announced it has raised $9.6 million in Series A extension financing, which brings the total round to $14.7 million. The series A extension financing was co-led by new investors Fusion Fund and Wavemaker Partners (Draper Venture Network). D ...
Savonix, a San Francisco, CA-based cognitive health company, completed a $9.6M Series A extension financing. The round, which brought total funding to date to $14.7M, was co-led by new investors Fusion Fund and Wavemaker Partners (Draper Venture Network), with participation from DEFTA Partners ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 14 | 250% | $72.9M |
#2 | $2M | 14 | -61% | N/A |
#3 | $0.5M | 14 | -90% | $61.8M |
#4 | $0.4M | 14 | 17% | $801.5M |
#5 | $1.2M | 14 | N/A | N/A |